Pharmaceuticals

Lack of enablement in Amgen v Sanofi and Regeneron

Amgen v Sanofi and Regeneron: Broad antibody patents held invalid for lack of enablement in US Lack of enablement: A conclusion of lack of enablement means that the disclosure provided in the patent specification, at the time the application was filed, would not have taught one skilled in the art how to make and/or use the full… Read more »

Patenting in the Pandemic

Partner Dr. Lawrence King reflects on Patenting in the Pandemic and the importance of locking down innovation in troubled times in this article, first published in The Chemical Engineer. The importance of locking down innovation in troubled times TO MOST, A Poor Man’s Tale of a Patent, published in October 1850, remains one of Charles Dickens’ lesser-known… Read more »

UKIPO “Green Channel” – can the patent system encourage more innovation in green technologies?

Partners Mike Jennings and Alex Bone explore the UKIPO “Green Channel” At AA Thornton, our patent attorneys have a long history of assisting innovators seeking protection for a variety of green technology including solar technology, waste processing and wind turbines.  Some of our clients were kind enough to share their stories with us, and you… Read more »

Access to Intellectual Property (IP) Rights in a Time of Emergency – Patent Pools and Beyond

Access to Intellectual Property (IP) Rights in a Time of Emergency – Patent Pools and Beyond This article was first published in BioScience Today The pharmaceutical and healthcare industry is often accused of misusing IP to extend exclusivity and delay reasonably priced access to life saving technologies. The recent pandemic has focussed attention on the… Read more »

WTR Anti-counterfeiting: A Global Guide 2020

Anti-counterfeiting: A Global Guide 2020 This article first appeared in Anti-counterfeiting: A Global Guide 2020, a supplement to World Trademark Review, published by Law Business Research – IP Division. To view the guide in full, please go to www.WorldTrademarkReview.com. For a further year, Senior Associates Louise Foster, Trade Mark Attorney and  Varuni Parantivatine, Solicitor, have… Read more »

Legal update – UK IPO COVID-19 response

Legal update – UK IPO coronavirus response In recognition of the challenges individuals and businesses are facing amidst the coronavirus outbreak, the UK Intellectual Property Office (UK IPO) has made certain temporary adjustments to its practices, to ensure that parties are not adversely affected in their dealings with the Office. It has also had to… Read more »

Artificial Intelligence – Our March 2020 report

Artificial Intelligence – Our March 2020 report According to the European Patent Office, for the first time in more than a decade, digital technologies have taken the lead in patent applications filed. Among the top technical fields digital communication (+19.6%) and computer technology (+10.2%) saw the steepest growth. The report, published on the 12th March… Read more »

BioScience Today article: Shanks v Unilever – An opening of the claim floodgates?

Solicitor Varuni Paranavitane writes for BioScience Today on the subject of Shanks v Unilever – An opening of the claim floodgates? This article was originally written for BioScience today, you can find Varuni’s article below, or read the full magazine here.   BACKGROUND In 2006 Professor Shanks claimed compensation under s40 of the Patents Act on… Read more »

Categories

Archives